GLB Prevents Tumor Metastasis of Lewis Lung Carcinoma by Inhibiting Tumor Adhesion Actions

Yan Pan,Qian-liu Song,Yan-hua Lin,Ning Lu,He-ming Yu,Xue-jun Li
DOI: https://doi.org/10.1111/j.1745-7254.2005.00125.x
2005-01-01
Abstract:Aim: To investigate the inhibitory effect of a new compound of GLB on tumor metastasis in vivo and analyze its actions on tumor cell adhesion to clarify its mechanism. Methods: The effect of GLB on tumor metastasis was analyzed by Lewis lung carcinoma model. The pathological morphology of lung alveolar was evaluated by hematoxylin-eosin staining. The effect of GLB on the proliferation of human prostate cancer cell (PC-3M, with a high metastatic characteristic) was studied using the MTT method, and its actions on PC-3M cell adhesion to human umbilical vein endothelial cells (HUVEC) and laminin were analyzed in vitro . Results: GLB (100 mg·kg −1 ·d −1 for 28 d, ig) reduced the number of lung colonies of Lewis lung carcinoma metastasis significantly ( P < 0.05). Simultaneously, GLB could mitigate the damage of lung alveolar caused by metastasic tumor deposits. In vitro , GLB inhibited dramatically the adhesion of PC-3M cells to HUVEC ( P < 0.01) and laminin ( P < 0.05), without cytotoxic or anti-proliferative action on PC-3M cells. Conclusion: GLB has anti-tumor metastatic activity, which partly depends on its inhibition of tumor adhesion.
What problem does this paper attempt to address?